30 Apr 2017 | Livemint.com

BSE
NSE
Last Updated: Mar 31, 03:41 PM
Bacil Pharma Ltd.

BSE

  • 7.15 0.00 (0%)
  • Vol: 600
  • BSE Code: 524516
  • PREV. CLOSE
    7.15
  • OPEN PRICE
    7.15
  • BID PRICE (QTY.)
    0.00(0)
  • OFFER PRICE (QTY.)
    0.00(0)

NSE

  • (%)
  • Vol:
  • NSE Code:
  • PREV. CLOSE
  • OPEN PRICE
  • BID PRICE (QTY.)
    ()
  • OFFER PRICE (QTY.)
    ()

Bacil Pharma Ltd. Board Meetings

From date
To date
Source Date Board Meeting Date Details
25-Apr-201727-Apr-2017 Intimation of Board Meeting
23-Jan-201730-Jan-2017 Quarterly Results
09-Nov-201614-Nov-2016With reference to the earlier latter dated November 03, 2016, Bacil Pharma Ltd has now informed BSE that the Meeting of Board of Directors of the Company is preponed / rescheduled from November 15, 2016, to November 14, 2016.
08-Nov-201615-Nov-2016 Quarterly Results
16-Aug-201613-Aug-2016 Quarterly Results & Bacil Pharma Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on August 13, 2016, inter alia, to consider and approve the followings: 1. Company’s Unaudited Quarterly Financial Results for the Quarter ended June 30, 2016. 2. Notice of Annual General Meeting for the Financial Year 2015 - 2016. 3. Board of Director’s Report for the Financial Year 2015 - 2016.
20-May-201630-May-2016 Audited Results & Bacil Pharma Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 30, 2016, inter alia, to consider and approve the Followings: 1. Audited Annual Financial Results for the Financial Year ended on March 31, 2016. 2. Appointment of Internal Auditors of the Company for the Financial Year 2016-17. 3. Appointment of Secretarial Auditors of the Company for the Financial Year 2016-17.
03-Feb-201612-Feb-2016 The Board of Directors of the Company will be held on February 12, 2016, inter alia, to consider the followings: 1. To Consider and approve Unaudited Quarterly Financial Results for the Quarter ended December 31, 2015. 2. To adopt and execute Uniform Listing Agreement in accordance with SEBI Circular dated October 13, 2015. & Quarterly Results
03-Nov-201509-Nov-2015 Quarterly Results
10-Aug-201514-Aug-2015 Quarterly Results
25-Jun-201502-Jul-2015 Audited Results
11-May-201515-May-2015 Quarterly Results
23-Mar-201526-Mar-2015 The Board of Directors of the Company will be held on March 26, 2015, inter alia, to consider and take on record the following: 1. To consider appointment of Women Director as per provision of Companies Act, 2013. 2. To consider appointment of Company Secretary as per provision of Companies Act, 2013.
09-Feb-201514-Feb-2015 Quarterly Results
10-Nov-201414-Nov-2014 Quarterly Results
26-Aug-201428-Aug-2014 The Board of Directors of the Company will be held on August 28, 2014, inter alia, to consider the following; 1. To consider Draft Notice for Annual General Meeting. 2. To consider appointment of Chief Financial Officer as per provision of Companies Act, 2013. 3. To consider appointment of Women Director as per provision of Companies Act, 2013.
12-Aug-201414-Aug-2014 Quarterly Results